Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - pyridoxine hydrochloride, quantity: 1.16 mg (equivalent: pyridoxine, qty 950 microgram); calcium pantothenate, quantity: 2.73 mg (equivalent: pantothenic acid, qty 2.5 mg); potassium iodide, quantity: 98.3 microgram (equivalent: iodine, qty 75 microgram); concentrated fish omega-3 triglycerides, quantity: 250 mg (equivalent: docosahexaenoic acid, qty 125 mg; equivalent: eicosapentaenoic acid, qty 25 mg); cyanocobalamin, quantity: 1.3 microgram; folic acid, quantity: 250 microgram; zinc oxide, quantity: 6.82 mg (equivalent: zinc, qty 5.5 mg); selenomethionine, quantity: 81.3 microgram (equivalent: selenium, qty 32.5 microgram); iron (ii) glycinate, quantity: 19.22 mg (equivalent: iron, qty 5 mg); calcium carbonate, quantity: 125 mg (equivalent: calcium, qty 50 mg); riboflavin, quantity: 700 microgram; ascorbic acid, quantity: 30 mg; chromium picolinate, quantity: 121 microgram (equivalent: chromium, qty 15 microgram); thiamine nitrate, quantity: 700 microgram; biotin, quantity: 15 microgram; betacarotene, quantity: 2.4 mg; d-alpha-tocopherol, quantity: 3.5 mg; heavy magnesium oxide, quantity: 58.1 mg (equivalent: magnesium, qty 35 mg); nicotinamide, quantity: 9 mg; colecalciferol, quantity: 12.5 microgram - capsule, soft - excipient ingredients: vegetable oil; sunflower oil; soya oil; glycerol; hydrogenated vegetable oil; gelatin; iron oxide red; mannitol; purified water; yellow beeswax; lecithin; iron oxide black; medium chain triglycerides; maltodextrin; citric acid; vanillin - maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps maintains/support healthy foetal cns/brain development ; maintains/support healthy foetal development ; maintain/support healthy pregnancy ; maintain/support maternal health ; help to prevent neural tube defects such as spina bifida and/or anencephaly ; aid/assist healthy thyroid hormone production for pregnancy ; maintain/support healthy thyroid gland function for pregnancy

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsules are a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate.  animal reproduction studies have not been conducted with calcium acetate capsules, and there are no adequate and well controlled studies of calcium acetate capsules use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate capsules treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium a

United States - English - NLM (National Library of Medicine)

atlantic biologicals corps - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see ]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. warnings and precautions (5.1) the effects of calcium acetate

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - ascorbic acid, quantity: 280 mg; rutoside, quantity: 50 mg; hesperidin, quantity: 25 mg; rosa canina, quantity: 41.67 mg (equivalent: rosa canina, qty 250 mg); calcium ascorbate dihydrate, quantity: 266 mg (equivalent: ascorbic acid, qty 220 mg); citrus bioflavonoids extract, quantity: 25 mg - tablet, modified release - excipient ingredients: tartaric acid; acacia; purified talc; hypromellose; guar gum; magnesium stearate; colloidal anhydrous silica; hydrogenated vegetable oil; titanium dioxide; iron oxide yellow; carnauba wax; calcium phosphate; macrogol 400 - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support collagen formation ; maintain/support collagen health ; maintain/support general health and wellbeing ; maintain/support blood vessel health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; maintain/support wound healing

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - zinc amino acid chelate, quantity: 25 mg (equivalent: zinc, qty 5 mg); panax ginseng, quantity: 25 mg; allium sativum, quantity: 10 mg (equivalent: allium sativum, qty 30 mg); calcium pantothenate, quantity: 55 mg (equivalent: pantothenic acid, qty 50.39 mg); d-alpha-tocopheryl acid succinate, quantity: 82.64 mg; ascorbic acid, quantity: 550 mg; pyridoxine hydrochloride, quantity: 25 mg (equivalent: pyridoxine, qty 20.57 mg); betacarotene, quantity: 3 mg; selenium amino acid chelate, quantity: 7.5 mg (equivalent: selenium, qty 75 microgram); thiamine nitrate, quantity: 9.996 mg; menadione, quantity: 50 microgram - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; soy polysaccharide; hydrogenated vegetable oil; colloidal anhydrous silica; magnesium stearate; hypromellose; purified talc; carnauba wax; macrogol 400; ethylcellulose; methylcellulose; starch sodium octenyl succinate; maize starch; purified water; maize oil; dl-alpha-tocopherol - a multi vitamin and mineral supplement with herbs. anti-oxidant. blackmores bioact anti-oxidant formula has been formulated to help protect the body from potentially harmful free radicals (highly reactive chemicals) which may be generated by lifestyle factors such as excess dietary fats, cigarette smoke, alcohol, indigestion, pollutants and physical or emotional stress. an antioxidant and free radical scavenger.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 94 mg in 1 ml - calcium gluconate injection, usp is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy.  it is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets, osteomalacia, lead colic and magnesium sulfate overdosage.  calcium gluconate has also been employed to decrease capillary permeability in allergic conditions, nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs.  in hyperkalemia, calcium gluconate may aid in antagonizing the cardiac toxicity, provided the patient is not receiving digitalis therapy. calcium salts are contraindicated in patients with ventricular fibrillation or hypercalcemia.  intravenous administration of calcium is contraindicated when serum calcium levels are above normal.

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - calcium pantothenate, quantity: 31.5 mg (equivalent: pantothenic acid, qty 28.86 mg); calcium phosphate, quantity: 45 mg (equivalent: calcium, qty 17.4 mg); manganese sulfate monohydrate, quantity: 3.08 mg (equivalent: manganese, qty 1 mg); chromic chloride hexahydrate, quantity: 1.046 mg (equivalent: chromium, qty 200 microgram); magnesium phosphate tribasic, quantity: 48.4 mg (equivalent: magnesium, qty 10 mg); folic acid, quantity: 400 microgram; thiamine nitrate, quantity: 30 mg (equivalent: thiamine, qty 24.32 mg); d-alpha-tocopheryl acid succinate, quantity: 20.7 mg (equivalent: d-alpha-tocopheryl acid succinate, qty 25 iu); inositol, quantity: 50 mg; riboflavin, quantity: 10 mg; ascorbic acid, quantity: 150 mg; cyanocobalamin, quantity: 50 microgram; borax, quantity: 17.66 mg (equivalent: boron, qty 2 mg); potassium sulfate, quantity: 11.15 mg (equivalent: potassium, qty 5 mg); cupric sulfate pentahydrate, quantity: 786 microgram (equivalent: copper, qty 200 microgram); pyridoxine hydrochloride, quantity: 30 mg (equivalent: pyridoxine, qty 24.7 mg); selenomethionine, quantity: 162.5 microgram (equivalent: selenium, qty 65 microgram); zinc sulfate monohydrate, quantity: 16.62 mg (equivalent: zinc, qty 6 mg); potassium iodide, quantity: 131 microgram (equivalent: iodine, qty 100 microgram; equivalent: potassium, qty 30.8 microgram); nicotinamide, quantity: 30 mg; ferrous fumarate, quantity: 15.7 mg (equivalent: iron, qty 5 mg); biotin, quantity: 100 microgram; calcium hydrogen phosphate, quantity: 313.7 mg (equivalent: calcium, qty 92.5 mg); retinol acetate, quantity: 0.8625 mg (equivalent: vitamin a, qty 0.75 mg); colecalciferol, quantity: 0.005 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; hypromellose; magnesium stearate; hydrogenated vegetable oil; carnauba wax; microcrystalline cellulose; macrogol 400; titanium dioxide; ethylcellulose; macrogol 8000; iron oxide yellow; purified talc; calcium hydrogen phosphate; maize starch; gelatin; silicon dioxide; butylated hydroxytoluene; sucrose; dl-alpha-tocopherol; hydrolysed gelatin; hydrogenated soya oil - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support energy production ; maintain/support general health and wellbeing ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support nervous system health ; maintain/support nervous system function

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

amway (malaysia) sdn. bhd. - soy bean extract (glycine max l.); black cohosh (cimicifuga racemoca) root extract -

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - calcium pantothenate, quantity: 55 mg (equivalent: pantothenic acid, qty 50 mg); pyridoxine hydrochloride, quantity: 25 mg (equivalent: pyridoxine, qty 20.6 mg); selenomethionine, quantity: 32.2 microgram (equivalent: selenium, qty 13 microgram); calcium ascorbate, quantity: 121 mg (equivalent: ascorbic acid, qty 100 mg); ascorbic acid, quantity: 150 mg; d-alpha-tocopherol, quantity: 67.1 mg; thiamine nitrate, quantity: 10 mg; zinc amino acid chelate, quantity: 25 mg (equivalent: zinc, qty 5 mg); folic acid, quantity: 250 microgram; silybum marianum, quantity: 10 mg (equivalent: silybum marianum, qty 700 mg; equivalent: flavanolignans calculated as silybin, qty 8.4 mg); betacarotene, quantity: 3 mg; cyanocobalamin, quantity: 0.05 mg; vitis vinifera, quantity: 10 mg (equivalent: vitis vinifera, qty 1200 mg; equivalent: procyanidins (of vitis vinifera), qty 8.5 mg) - capsule, soft - excipient ingredients: gelatin; glycerol; iron oxide black; lecithin; iron oxide red; calcium hydrogen phosphate dihydrate; soya oil; ethanol; yellow beeswax; hydrogenated vegetable oil; purified water; mixed (low-alpha type) tocopherols concentrate; mannitol - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support body metabolism/metabolic rate ; maintain/support energy production ; maintain/support general health and wellbeing ; maintain/support blood health ; maintain/support artery health ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient)

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - calcium carbonate, quantity: 1.25 g (equivalent: calcium, qty 500 mg); colecalciferol, quantity: 0.005 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; carnauba wax; magnesium stearate; purified talc; maltodextrin; citric acid; microcrystalline cellulose; macrogol 8000; hypromellose; maize starch; silicon dioxide; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil; titanium dioxide - maintain/support healthy teeth ; maintain/support bone health ; maintain/support bone strength ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support maternal health